Manufacturer
Strides Pharma, Inc.
9 drugs, 18 product strengths, 14 recalls on record.
Drugs Strides Pharma, Inc. makes
Ibuprofen+1.5%Generic · 240 makersPharmacies pay from$1.019 open recallsCetirizine-4.2%Generic · 146 makersPharmacies pay from$1.365 open recallsLoratadine+3.5%Generic · 145 makersPharmacies pay from$1.641 open recallBuspirone-0.8%Generic · 40 makersPharmacies pay from$0.662 open recallsEmtricitabine / tenofovir disoproxil-0.5%Generic · 23 makersPharmacies pay from$15.79Loperamide+5.2%Generic · 103 makersPharmacies pay from$1.731 open recallAmantadine-1.1%Generic · 33 makersPharmacies pay from$4.232 open recallsLevonorgestrel+1.3%Generic · 14 makersPharmacies pay from$1921 open recallPotassium citrate-1.3%Generic · 11 makersPharmacies pay from$3.44
Recalls
Class IIOngoingOct 28, 2026Cinacalcet TabletsFailed dissolution specificationsStrides Pharma Inc · D-0079-2027Class IIOngoingMar 25, 2026Children's Ibuprofen Oral SuspensionPresence of foreign substance: the firm received complaints for a gel-like mass and black particles in the product.Strides Pharma Inc · D-0390-2026Class IIOngoingAug 6, 2025Cinacalcet Tablets 90 mgFailed Dissolution Specifications.Strides Pharma, Inc. · D-0546-2025Class IICompletedApr 2, 2025Testosterone Gel 1%Presence of foreign substance: Presence of Benzene.Strides Pharma, Inc. · D-0293-2025Class IICompletedApr 2, 2025Testosterone Gel 1%Presence of foreign substance: Presence of Benzene.Strides Pharma, Inc. · D-0294-2025Class IITerminatedJan 31, 2024Methoxsalen CapsulesFailed Dissolution SpecificationsStrides Pharma Inc. · D-0260-2024Class IITerminatedJul 12, 2023Losartan Potassium TabletsPresence of Foreign Substance: Presence of a small piece of blue plastic embedded in the tablet.Strides Pharma Inc. · D-0895-2023Class IITerminatedAug 17, 2022Prednisone Tablets USPPresence of foreign tablet: 2.5 mg tablet in a 20 mg bottle of Prednisone TabletsStrides Pharma Inc. · D-1330-2022Class IITerminatedJun 8, 2022Losartan Potassium TabletsCGMP Deviations- AZIDO Impurity levels observed to be above acceptable limitsStrides Pharma Inc. · D-0972-2022Class IITerminatedJun 8, 2022Losartan Potassium TabletsCGMP Deviations- AZIDO Impurity levels observed to be above acceptable limitsStrides Pharma Inc. · D-0973-2022Class IITerminatedJun 8, 2022Losartan Potassium TabletsCGMP Deviations- AZIDO Impurity levels observed to be above acceptable limitsStrides Pharma Inc. · D-0974-2022Class IITerminatedOct 20, 2021Potassium Chloride Extended-Release TabletsFailed Dissolution SpecificationsStrides Pharma Inc. · D-0006-2022Class IIITerminatedJan 6, 2021NDC 64380-721-06 TACROLIMUS CAPSULESFailed Moisture LimitsStrides Pharma Inc. · D-0180-2021Class IIITerminatedMay 31, 2017Benzonatate capsulesFailed Stability Specifications: Out of Specification results obtained for preservative Methylparaben content.Strides Pharma INC · D-0858-2017
About Strides Pharma, Inc.
No comments yet. Questions, tips, what worked for you - start the conversation.